rs2153960 — FOXO3

FOXO3's IGF-1 Regulatory Locus — The Signal Behind the Signal

FOXO3 encodes the most consistently replicated longevity gene in human genetics. But not every variant within FOXO3 is a longevity signal — and rs2153960 illustrates that distinction with unusual clarity. This intronic SNP does not itself associate with exceptional lifespan in large meta-analyses, yet it sits at a locus whose biological output — modulation of circulating insulin-like growth factor 1 (IGF-1) — is directly connected to how FOXO3 protein exerts its anti-aging effects. Understanding rs2153960 means understanding the IGF-1/FOXO3 axis that makes FOXO3 one of the most consequential longevity genes ever identified.

Kaplan et al. 2011¹¹ Kaplan et al. 2011
A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3. Hum Mol Genet. 2011 conducted a GWAS of 10,280 middle-aged and older adults from four community cohorts, finding a borderline genome-wide significant association between rs2153960 and serum IGF-1 concentration (p = 5.1 × 10⁻⁷), and noting that this locus was "associated with longevity." The signal was subsequently confirmed at full genome-wide significance in a larger meta-analysis of 30,884 European-ancestry adults across 21 studies, which explicitly described rs2153960 as "the known longevity-associated variant (FOXO3)" and highlighted it as evidence for "the IGF axis in mediating effects of known (FOXO3) and novel longevity-associated loci."

The Mechanism

The insulin/IGF-1 signaling (IIS) pathway is evolution's primary master regulator of lifespan across metazoans — the same pathway that extends lifespan in nematodes, flies, mice, and is associated with human longevity. FOXO3 sits at the nexus of this pathway: when IGF-1 levels are low, the PI3K-AKT cascade is inactive, FOXO3 remains unphosphorylated and translocates to the nucleus, where it activates hundreds of genes involved in oxidative stress resistance, DNA repair, autophagy, and controlled apoptosis of damaged cells. When IGF-1 is high, AKT phosphorylates FOXO3 and traps it in the cytoplasm, silencing its protective program.

rs2153960 lies in intron 2 of FOXO3, a 101,625 base-pair noncoding region that contains multiple independent regulatory elements. As an intronic variant with no confirmed functional characterization (unlike rs2802292, which has a demonstrated HSF1 binding site mechanism), rs2153960 likely tags a nearby regulatory element that influences either FOXO3 expression or a gene in the same chromatin domain. The A allele associates with higher circulating IGF-1 at genome-wide significance. Higher IGF-1 means more AKT activation, more FOXO3 nuclear exclusion, and attenuated longevity pathway activation — the opposite of what the established longevity-associated G alleles at rs2802292 and rs2764264 achieve.

The ²² GWAS Catalog records additional associations for rs2153960 including cortical thickness (G allele, p = 3 × 10⁻¹⁶) and subcortical brain volumes — associations likely reflecting LD with nearby FOXO3 regulatory variants that influence brain-expressed FOXO3 activity, consistent with FOXO3's documented role in neuronal stress resistance and cognitive aging.

The Evidence

The primary evidence for rs2153960 is metabolic, not longevity-specific. The FOXO3 locus as a whole is one of the most replicated longevity signals in human genetics — the rs2802292³³ rs2802292
the primary FOXO3 longevity variant with a characterized HSF1-binding mechanism variant has been replicated in every human population studied. rs2153960 tags this same locus but is a distinct regulatory signal: it is correlated with IGF-1 levels but is NOT the functional longevity variant itself.

Bao et al. 2014⁴⁴ Bao et al. 2014
Association between FOXO3A gene polymorphisms and human longevity: a meta-analysis. Asian J Androl. 2014 examined 11 independent FOXO3 longevity studies and explicitly found "no association between rs2153960, rs7762395 or rs13220810 polymorphisms and longevity," while confirming associations for rs2802292, rs2764264, rs13217795, rs1935949, and rs2802288. This establishes rs2153960 as a metabolic biomarker variant at the FOXO3 locus rather than a direct longevity variant in its own right.

This distinction matters for interpretation. The variant's value is contextual: it captures variation in IGF-1 signaling tone that may modify how effectively FOXO3's protective mechanisms operate across decades. Notable population frequency differences — the A allele is common (~70%) in Europeans and East Asians but rare (~17%) in Africans — suggest this variant arose or rose to high frequency in non-African populations through mechanisms that may relate to historical differences in nutrition or growth environments, though this is speculative.

Practical Implications

For individuals carrying the AA or AG genotype (the common pattern in most non-African populations), the relevant consideration is that their FOXO3 locus may be tagging a higher-IGF-1 regulatory state. This makes lifestyle interventions that lower IGF-1 and directly activate FOXO3 especially relevant — caloric restriction, protein cycling (lower animal protein), and extended fasting all reliably reduce IGF-1 and restore FOXO3 nuclear access.

For GG carriers (the ancestrally enriched genotype, most common in individuals of African ancestry), the locus tags a lower-IGF-1 regulatory state that may represent better baseline FOXO3 activation capacity. This is consistent with the well-established principle in longevity biology that lower-normal IGF-1 (100–150 ng/mL) is associated with healthier aging trajectories.

In all cases, the evidence-based interventions for supporting FOXO3 signaling — fasting, plant-protein diets, resistance training, and HIIT — remain the most actionable tools, regardless of genotype at this locus.

Interactions

rs2153960 is located in the same 101,625 base-pair FOXO3 intron 2 that harbors rs2802292 (the primary longevity variant whose G allele creates an HSF1 binding site) and rs12212067 (the MZF1-binding anti-inflammatory variant). The mechanisms are distinct: rs2802292 adds a stress-activated enhancer, while rs2153960 tags IGF-1 regulatory capacity. Together, these provide a more complete picture of FOXO3 regulatory architecture than any single variant alone. Carriers who are GG at rs2153960 (lower IGF-1 tone) AND GG at rs2802292 (enhanced stress-response FOXO3 activation) would have the most favorable combined FOXO3 regulatory state.

The rs35767⁵⁵ rs35767
IGF-1 promoter variant independently affecting IGF-1 transcription in the IGF1 gene itself provides complementary information about the IGF-1/FOXO3 axis from the ligand side; individuals with low-IGF-1 variants at both the IGF1 locus and the FOXO3 locus may have particularly robust FOXO3 pathway activation.